property type: Life Sciences

Philadelphia Business Journal A venture of Cantor Fitzgerald, Silverstein Properties Inc. and University Place Associates is planning on constructing a 250,000-square-foot life-sciences and office building in Philadelphia. The eight-story property, at 4101 Market St. in the University City area, will ...

Spear Street Capital has sold a 90 percent stake in the Arborcrest Corporate Campus in the Philadelphia suburb of Blue Bell, Pa., in a deal valuing the 855,600-square-foot complex at $225 million, or nearly $263/sf. The San Francisco investment manager ...

Boston Business Journal King Street Properties plans to build a 700,000-square-foot life-sciences complex in the Boston suburb of Devens, Mass. The Boston developer is constructing the five-building property on a 45-acre site on Jackson Road. The project is expected to ...

Breakthrough Properties, which was formed last year by a venture of Tishman Speyer Properties and Bellco Capital, has completed raising more than $1 billion for a commingled fund and co-investments that would be used to fund the development and purchase of ...

Commercial Real Estate Direct Staff Report IQHQ Inc., which was founded last year by the former chief executive and president of BioMed Realty Trust Inc., has raised $1.7 billion of equity commitments through a private placement with institutional investors. The ...

Commercial Real Estate Direct Staff Report Brookfield Asset Management Inc. is offering for sale a portfolio of 13 life-sciences properties with about 2.3 million square feet in Cambridge, Mass., Baltimore and Philadelphia. The Toronto investment manager assumed the properties two ...

A venture of Bain Capital Real Estate and Phase 3 Real Estate Partners Inc. has completed the sale of the Genesis South San Francisco life-sciences complex to Ventas Inc., in a deal valued at $1.02 billion, or $1,280.50/sf. The three-building ...